spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  
EVENTS FOR 2020
   
 
EVENTS FOR ALL MAGAZINES
 
     

Evolution Summit

20-22 July 2020
The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development. More>>

 
web events.marcusevans-events.com/evolutionmay-2020/
email The Ritz Carlton, Fort Lauderdale, FL
 

INTERPHEX 2020

15-17 July 2020
Javits Center NYC

More>>

 
phone (203) 840-5455
email KScott@reedexpo.com
web bit.ly/2ET106L
email Javits Center, New York, USA
 

Formulation and Drug Delivery Series UK

8-9 July 2020
Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development. More>>

 
phone 01865 248455
email e.hawkings@oxfordglobal.co.uk
web https://bit.ly/2SXCR4w
email Search Results Godstow Court, Minns Business Park, Botley, Oxford OX2 0JB
 
spacer
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

White Papers

News and Press Releases

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement